–  moksha8 and BioCryst Gain Approval for the Importation and Use of Peramivir in Mexico for
    the Treatment of H1N1 Influenza. moksha8 also announces $25M financing led
    by Montreux Equity Partners
 –  moksha8 Expands Alliance with Roche to Commercialize $200M of Products in Brazil and Mexico
–  moksha8 Launches Broad Product Portfolio in Key Emerging Markets

_________________________________________________________

Jeannine MEDEIROS
Vice President, Human Resources and Investor Relations
T + 852 9191 0375
_________________________________________________________

For more information, Investor Relations and Media-related inquiries, please contact:

Jeannine Medeiros Investor and Media Relations Tel: +852 9191 0375 jeannine@moksha8.com